TY - JOUR
T1 - Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals
AU - Nugent, Rachel
AU - Bertram, Melanie Y.
AU - Jan, Stephen
AU - Niessen, Louis W.
AU - Sassi, Franco
AU - Jamison, Dean T.
AU - Pier, Eduardo González
AU - Beaglehole, Robert
N1 - Funding Information:
We thank Dan Chisholm for valuable feedback on the contents of this paper. RN received support from the Bill & Melinda Gates Foundation through the DCPN at the University of Washington until 2016, and from RTI International subsequently. We thank Jinyuan Qi, Salin Sriudomporn, and Ishu Kataria for assistance with research. The Taskforce authors are grateful to the International Development Research Center, Ottawa, Canada, for supporting author meetings.
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/5/19
Y1 - 2018/5/19
N2 - Reduction of the non-communicable disease (NCD) burden is a global development imperative. Sustainable Development Goal (SDG) 3 includes target 3·4 to reduce premature NCD mortality by a third by 2030. Progress on SDG target 3·4 will have a central role in determining the success of at least nine SDGs. A strengthened effort across multiple sectors with effective economic tools, such as price policies and insurance, is necessary. NCDs are heavily clustered in people with low socioeconomic status and are an important cause of medical impoverishment. They thereby exacerbate economic inequities within societies. As such, NCDs are a barrier to achieving SDG 1, SDG 2, SDG 4, SDG 5, and SDG 10. Productivity gains from preventing and managing NCDs will contribute to SDG 8. SDG 11 and SDG 12 offer clear opportunities to reduce the NCD burden and to create sustainable and healthy cities.
AB - Reduction of the non-communicable disease (NCD) burden is a global development imperative. Sustainable Development Goal (SDG) 3 includes target 3·4 to reduce premature NCD mortality by a third by 2030. Progress on SDG target 3·4 will have a central role in determining the success of at least nine SDGs. A strengthened effort across multiple sectors with effective economic tools, such as price policies and insurance, is necessary. NCDs are heavily clustered in people with low socioeconomic status and are an important cause of medical impoverishment. They thereby exacerbate economic inequities within societies. As such, NCDs are a barrier to achieving SDG 1, SDG 2, SDG 4, SDG 5, and SDG 10. Productivity gains from preventing and managing NCDs will contribute to SDG 8. SDG 11 and SDG 12 offer clear opportunities to reduce the NCD burden and to create sustainable and healthy cities.
UR - http://www.scopus.com/inward/record.url?scp=85044850719&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044850719&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(18)30667-6
DO - 10.1016/S0140-6736(18)30667-6
M3 - Review article
C2 - 29627167
AN - SCOPUS:85044850719
SN - 0140-6736
VL - 391
SP - 2029
EP - 2035
JO - The Lancet
JF - The Lancet
IS - 10134
ER -